GERALD ROSENBERG: Open Payments
NPI 1649249624 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,881 in 126 payments from 15 companies in 2025. Trend: 2023 $3,071 · 2024 $1,845 · 2025 $1,881
Food & beverage: $1,881
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $328 |
| GlaxoSmithKline, LLC. | 20 | $298 |
| Janssen Biotech, Inc. | 26 | $289 |
| Amgen Inc. | 25 | $286 |
| AstraZeneca Pharmaceuticals LP | 9 | $264 |
| ABBVIE INC. | 20 | $206 |
| UCB, Inc. | 4 | $58 |
| Medtronic, Inc. | 1 | $37 |
| Almatica Pharma LLC | 1 | $23 |
| Grifols USA, LLC | 1 | $19 |
Products named: COSENTYX, BENLYSTA, TREMFYA, SAPHNELO, RINVOQ, KRYSTEXXA, Bimzelx, TAVNEOS.
Industry payments across TX — which companies pay providers there.
